-
04:23:36 PM
Sign in with email
Forgot your password?
Register with email
Account Verification

Trending News

Covid-19 News LIVE

The stock market news feed is automatically updated to show the latest 50 news.
The news is in real time for GOLD users while a 15 second delay is applied for FREE users.

Become a Gold member to unlock the feed filters, voice notification and see the news without delay.

Check out our Stock Market News Today and Join our Discord

09/29/22 10:02 AM
AMEX : SSY
earningscovid-19low float
SunLink Health Systems, Inc. Announces Fiscal 2022 Fourth Quarter and Annual Results and COVID-19 Update
SunLink Health Systems, Inc. today announced a loss from continuing operations of $2,317,000 for its fourth fiscal quarter ended June 30, 2022 compared to earnings from continuing operations of $4,555,000 for the fourth fiscal quarter ended June 30, 2021. Net loss for the quarter ended June 30, 2022 was $2,365,000 compared to net earnings of $4,687,000 for...
RHEA-AI
negative
09/26/22 9:00 AM
OTC : SING
covid-19
SinglePoint Subsidiary, BPA Solutions, Announces New Consulting Services for Assisting Government and Non-profit Entities with FEMA Reimbursement for COVID-19 Related Expenses
FEMA provides government, schools, and non-profit organizations with reimbursement for COVID-19-related purchases, including indoor air purification BPA Solutions is partnering with specialized FEMA consultants to expedite the application process for 178,000 organizations that appear in the system
RHEA-AI
very positive
09/20/22 6:15 AM
Nasdaq : BVXV
covid-19low float
BiondVax's Strategic Research Collaboration with Max Planck and UMG: Significant progress towards development of innovative nanosized antibodies (NanoAbs) for therapeutic indications in addition to COVID-19
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today provided encouraging updates related to the
RHEA-AI
very positive
09/16/22 6:39 AM
Nasdaq : GILD
covid-19
CHMP Adopts Positive Opinion to Extend Indication of Veklury(R) (Remdesivir) for the Treatment of Pediatric Patients with COVID-19
Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion to extend the indication of Veklury (R) for the treatment of pediatric patients who do not require supplemental oxygen and are at increased risk of progressing to severe COVID-19 and pediatric patients...
RHEA-AI
neutral
09/15/22 6:21 PM
Nasdaq : GILD
covid-19
WHO Expands Recommendation for Veklury(R) (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline
The WHO conditional recommendation for Veklury' s use in the treatment of patients with severe COVID-19 is mainly driven by the final results of the WHO- sponsored SOLIDARITY study, which showed a statistically significant 17% lower relative risk of death or progression to needing ventilation in patients requiring supplemental oxygen at baseline,...
RHEA-AI
neutral
09/15/22 12:00 PM
Nasdaq : AZN
partnershipcovid-19
AstraZeneca Partners with Jeff Bridges, Kumail Nanjiani, and Emily V. Gordon to Educate the Immunocompromised Community about Added Protection Against COVID-19
Today, AstraZeneca launched Up The Antibodies, an important new campaign that embraces the reality for millions of immunocompromised Americans 1,2: COVID-19 isn' t over. Up The Antibodies, a new educational campaign from AstraZeneca with Jeff Bridges and other iconic voices to help educate the immunocompromised community about added protection against...
RHEA-AI
neutral
09/15/22 9:06 AM
Nasdaq : OMER
covid-19
Omeros Corporation Reports Narsoplimab Treatment Results in Critically Ill COVID-19 Patients in I-SPY COVID Trial
Omeros Corporation today reported results from the narsoplimab arm of the I-SPY COVID Trial, sponsored by Quantum Leap Healthcare Collaborative. Analysis in the randomized patient population shows that the addition of narsoplimab to treatment of critically ill patients with COVID-19 reduces the mortality risk (hazard ratio[ HR]= 0.81, with probability[ HR.
RHEA-AI
neutral
09/15/22 9:02 AM
Nasdaq : OMER
covid-19
I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Reports Assessment of Narsoplimab for Treatment of Critically Ill Patients With COVID-19
Quantum Leap Healthcare Collaborative, sponsor of the I-SPY COVID Trial, and Omeros Corporation, developer of the investigational agent narsoplimab, announced that enrollment has been closed and data have been analyzed in the narsoplimab arm of the I-SPY COVID Trial. The analysis in the randomized patient population, including those...
RHEA-AI
negative
09/14/22 10:00 AM
Nasdaq : CMCSA
covid-19
Comcast RISE Investment Fund Provides $21 Million in Grants to Support Small Businesses Hardest Hit by the COVID-19 Pandemic
Today, Comcast announced a new round of cities will receive grants from the Comcast RISE Investment Fund, providing an additional $5 million to hundreds of small businesses owned by people of color, including Black, Indigenous, Hispanic, and Asian American owners, and women, bringing the total to $21 million in grants awarded as part of the Investment Fund...
RHEA-AI
very positive
09/14/22 7:00 AM
OTC : VPHIF
covid-19
VALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES AGREEMENT WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH COVID-19 AT HIGH RISK FOR ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
In a Phase 3 cinical study interim analysis, sabizabulin showed a 55.2% reduction in deaths compared to placebo in hospitalized adult patients with moderate-severe COVID-19 who are at high risk for ARDS Sabizabulin also showed significant reduction of days in ICU, days on mechanical ventilation and
RHEA-AI
neutral
09/12/22 11:20 AM
NYSE, Nasdaq : PFE, BNTX
covid-19
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
Pfizer Inc. and BioNTech SE today announced a 30- ug booster dose of their Omicron BA.4/BA. 5 bivalent-adapted COVID-19 Vaccine has been recommended for conditional marketing authorization by the European Medicines Agency' s Committee for Medicinal Products for Human Use for individuals ages 12 years and older.
RHEA-AI
neutral
09/12/22 7:15 AM
Nasdaq : ADGI, IVVD
covid-19
Invivyd Announces Multiple Next Generation COVID-19 Antibody Candidates and Selects Combination for Clinical Advancement Based on Positive in vitro Data Against Omicron Variants
Integrated discovery platform is producing a stream of candidate antibodies demonstrating broad in vitro neutralization against past variants of concern (e.g., D614G, beta, delta) and Omicron sublineages BA.1, BA.2, BA.4, BA.5 and BA.2.75, as well as SARS-CoV-1 Antibodies target highly conserved
RHEA-AI
neutral
09/07/22 8:30 AM
Nasdaq : ENTA
clinical trialcovid-19low float
New Preclinical Data for EDP-235, Enanta's Oral Coronavirus Protease Inhibitor Designed for the Treatment of COVID-19, to be Presented at IDWeek(TM) 2022
Enanta Pharmaceuticals, Inc., a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that new preclinical data for EDP-235, its lead oral coronavirus protease inhibitor specifically designed for the treatment of COVID-19, will be presented at IDWeek 2022 being held...
RHEA-AI
neutral